HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.

Abstract
Termination of early pregnancy (less than 49 days of amenorrhea) was induced in 75 patients with the combination of the antigestagen mifepristone and a prostaglandin analogue, meteneprost. After 48 h a single oral dose of 600 mg of mifepristone was followed by a 10 mg meteneprost vaginal pessary. Pregnancy was confirmed by clinical and ultrasound examinations and plasma HCG assessment. Complete abortion occurred in 72 patients (96%) and the three others required a surgical uterine aspiration. Bleeding continued for 4 to 12 days (mean = 8). Uterine pain and side effects occurred during the 3 h following the use of prostaglandin. Only minor analgesic were required in 30 patients. The combination of mifepristone and meteneprost is a safe and effective method to terminate an early pregnancy.
AuthorsB Maria, F Stampf, A Goepp, C Dubois
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 37 Issue 1 Pg. 35-40 (Oct 1990) ISSN: 0301-2115 [Print] Ireland
PMID2376278 (Publication Type: Journal Article)
Chemical References
  • Abortifacient Agents
  • Abortifacient Agents, Nonsteroidal
  • Prostaglandins E, Synthetic
  • meteneprost
  • Mifepristone
  • 16,16-Dimethylprostaglandin E2
Topics
  • 16,16-Dimethylprostaglandin E2 (administration & dosage, adverse effects, analogs & derivatives)
  • Abortifacient Agents (administration & dosage)
  • Abortifacient Agents, Nonsteroidal (administration & dosage, adverse effects)
  • Abortion, Induced (methods)
  • Abortion, Legal
  • Administration, Intravaginal
  • Administration, Oral
  • Adolescent
  • Adult
  • Female
  • France
  • Humans
  • Mifepristone (administration & dosage, adverse effects)
  • Pregnancy
  • Pregnancy Trimester, First
  • Prostaglandins E, Synthetic (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: